Selected research
Market Analysis & Forecast
Global Epilepsy Devices Market Analysis and Forecast 2026-2032
Market perspective
The global Epilepsy Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Epilepsy Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Epilepsy Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Epilepsy Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Epilepsy Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Epilepsy Devices include Medtronic, Nihon Kohden Corporation, Neuropace, Natus Medical Incorporated, Medpage, MC10, Liva Nova, Koninklijke Philips and Jude Medical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Epilepsy Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Epilepsy Devices, also provides the sales of main regions and countries. Of the upcoming market potential for Epilepsy Devices, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Epilepsy Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Epilepsy Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Epilepsy Devices sales, projected growth trends, production technology, application and end-user industry.
Epilepsy Devices Segment by Company
Medtronic
Nihon Kohden Corporation
Neuropace
Natus Medical Incorporated
Medpage
MC10
Liva Nova
Koninklijke Philips
Jude Medical
Empatica
Compumedics
Cerbomed
Boston Scientific Corporation
Epilepsy Devices Segment by Type
Conventional Devices
Wearable Devices
Implantable Devices
Epilepsy Devices Segment by Application
Hospitals
Neurology Centers
Others
Epilepsy Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epilepsy Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Epilepsy Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epilepsy Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Epilepsy Devices in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Epilepsy Devices manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Epilepsy Devices sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Conventional Devices
- Wearable Devices
- Implantable Devices
Applications
- Hospitals
- Neurology Centers
- Others
Companies covered
- Medtronic
- Nihon Kohden Corporation
- Neuropace
- Natus Medical Incorporated
- Medpage
- MC10
- Liva Nova
- Koninklijke Philips
- Jude Medical
- Empatica
- Compumedics
- Cerbomed
- Boston Scientific Corporation
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Epilepsy Devices Market by Type
- 1.2.1 Global Epilepsy Devices Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Conventional Devices
- 1.2.3 Wearable Devices
- 1.2.4 Implantable Devices
- 1.3 Epilepsy Devices Market by Application
- 1.3.1 Global Epilepsy Devices Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospitals
- 1.3.3 Neurology Centers
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Epilepsy Devices Market Dynamics
- 2.1 Epilepsy Devices Industry Trends
- 2.2 Epilepsy Devices Industry Drivers
- 2.3 Epilepsy Devices Industry Opportunities and Challenges
- 2.4 Epilepsy Devices Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Epilepsy Devices Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Epilepsy Devices Revenue by Region
- 3.2.1 Global Epilepsy Devices Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Epilepsy Devices Revenue by Region (2021-2026)
- 3.2.3 Global Epilepsy Devices Revenue by Region (2027-2032)
- 3.2.4 Global Epilepsy Devices Revenue Market Share by Region (2021-2032)
- 3.3 Global Epilepsy Devices Sales Estimates and Forecasts 2021-2032
- 3.4 Global Epilepsy Devices Sales by Region
- 3.4.1 Global Epilepsy Devices Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Epilepsy Devices Sales by Region (2021-2026)
- 3.4.3 Global Epilepsy Devices Sales by Region (2027-2032)
- 3.4.4 Global Epilepsy Devices Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Epilepsy Devices Revenue by Manufacturers
- 4.1.1 Global Epilepsy Devices Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Epilepsy Devices Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Epilepsy Devices Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Epilepsy Devices Sales by Manufacturers
- 4.2.1 Global Epilepsy Devices Sales by Manufacturers (2021-2026)
- 4.2.2 Global Epilepsy Devices Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Epilepsy Devices Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Epilepsy Devices Sales Price by Manufacturers (2021-2026)
- 4.4 Global Epilepsy Devices Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Epilepsy Devices Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Epilepsy Devices Manufacturers, Product Type & Application
- 4.7 Global Epilepsy Devices Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Epilepsy Devices Market CR5 and HHI
- 4.8.2 2025 Epilepsy Devices Tier 1, Tier 2, and Tier 3
5 Epilepsy Devices Market by Type
- 5.1 Global Epilepsy Devices Revenue by Type
- 5.1.1 Global Epilepsy Devices Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Epilepsy Devices Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Epilepsy Devices Revenue Market Share by Type (2021-2032)
- 5.2 Global Epilepsy Devices Sales by Type
- 5.2.1 Global Epilepsy Devices Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Epilepsy Devices Sales by Type (2021-2032) & (k units)
- 5.2.3 Global Epilepsy Devices Sales Market Share by Type (2021-2032)
- 5.3 Global Epilepsy Devices Price by Type
6 Epilepsy Devices Market by Application
- 6.1 Global Epilepsy Devices Revenue by Application
- 6.1.1 Global Epilepsy Devices Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Epilepsy Devices Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Epilepsy Devices Revenue Market Share by Application (2021-2032)
- 6.2 Global Epilepsy Devices Sales by Application
- 6.2.1 Global Epilepsy Devices Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Epilepsy Devices Sales by Application (2021-2032) & (k units)
- 6.2.3 Global Epilepsy Devices Sales Market Share by Application (2021-2032)
- 6.3 Global Epilepsy Devices Price by Application
7 Company Profiles
- 7.1 Medtronic
- 7.1.1 Medtronic Company Information
- 7.1.2 Medtronic Business Overview
- 7.1.3 Medtronic Epilepsy Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Medtronic Epilepsy Devices Product Portfolio
- 7.1.5 Medtronic Recent Developments
- 7.2 Nihon Kohden Corporation
- 7.2.1 Nihon Kohden Corporation Company Information
- 7.2.2 Nihon Kohden Corporation Business Overview
- 7.2.3 Nihon Kohden Corporation Epilepsy Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Nihon Kohden Corporation Epilepsy Devices Product Portfolio
- 7.2.5 Nihon Kohden Corporation Recent Developments
- 7.3 Neuropace
- 7.3.1 Neuropace Company Information
- 7.3.2 Neuropace Business Overview
- 7.3.3 Neuropace Epilepsy Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Neuropace Epilepsy Devices Product Portfolio
- 7.3.5 Neuropace Recent Developments
- 7.4 Natus Medical Incorporated
- 7.4.1 Natus Medical Incorporated Company Information
- 7.4.2 Natus Medical Incorporated Business Overview
- 7.4.3 Natus Medical Incorporated Epilepsy Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Natus Medical Incorporated Epilepsy Devices Product Portfolio
- 7.4.5 Natus Medical Incorporated Recent Developments
- 7.5 Medpage
- 7.5.1 Medpage Company Information
- 7.5.2 Medpage Business Overview
- 7.5.3 Medpage Epilepsy Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Medpage Epilepsy Devices Product Portfolio
- 7.5.5 Medpage Recent Developments
- 7.6 MC10
- 7.6.1 MC10 Company Information
- 7.6.2 MC10 Business Overview
- 7.6.3 MC10 Epilepsy Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 MC10 Epilepsy Devices Product Portfolio
- 7.6.5 MC10 Recent Developments
- 7.7 Liva Nova
- 7.7.1 Liva Nova Company Information
- 7.7.2 Liva Nova Business Overview
- 7.7.3 Liva Nova Epilepsy Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Liva Nova Epilepsy Devices Product Portfolio
- 7.7.5 Liva Nova Recent Developments
- 7.8 Koninklijke Philips
- 7.8.1 Koninklijke Philips Company Information
- 7.8.2 Koninklijke Philips Business Overview
- 7.8.3 Koninklijke Philips Epilepsy Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Koninklijke Philips Epilepsy Devices Product Portfolio
- 7.8.5 Koninklijke Philips Recent Developments
- 7.9 Jude Medical
- 7.9.1 Jude Medical Company Information
- 7.9.2 Jude Medical Business Overview
- 7.9.3 Jude Medical Epilepsy Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Jude Medical Epilepsy Devices Product Portfolio
- 7.9.5 Jude Medical Recent Developments
- 7.10 Empatica
- 7.10.1 Empatica Company Information
- 7.10.2 Empatica Business Overview
- 7.10.3 Empatica Epilepsy Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Empatica Epilepsy Devices Product Portfolio
- 7.10.5 Empatica Recent Developments
- 7.11 Compumedics
- 7.11.1 Compumedics Company Information
- 7.11.2 Compumedics Business Overview
- 7.11.3 Compumedics Epilepsy Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Compumedics Epilepsy Devices Product Portfolio
- 7.11.5 Compumedics Recent Developments
- 7.12 Cerbomed
- 7.12.1 Cerbomed Company Information
- 7.12.2 Cerbomed Business Overview
- 7.12.3 Cerbomed Epilepsy Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 Cerbomed Epilepsy Devices Product Portfolio
- 7.12.5 Cerbomed Recent Developments
- 7.13 Boston Scientific Corporation
- 7.13.1 Boston Scientific Corporation Company Information
- 7.13.2 Boston Scientific Corporation Business Overview
- 7.13.3 Boston Scientific Corporation Epilepsy Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 Boston Scientific Corporation Epilepsy Devices Product Portfolio
- 7.13.5 Boston Scientific Corporation Recent Developments
8 North America
- 8.1 North America Epilepsy Devices Market Size by Type
- 8.1.1 North America Epilepsy Devices Revenue by Type (2021-2032)
- 8.1.2 North America Epilepsy Devices Sales by Type (2021-2032)
- 8.1.3 North America Epilepsy Devices Price by Type (2021-2032)
- 8.2 North America Epilepsy Devices Market Size by Application
- 8.2.1 North America Epilepsy Devices Revenue by Application (2021-2032)
- 8.2.2 North America Epilepsy Devices Sales by Application (2021-2032)
- 8.2.3 North America Epilepsy Devices Price by Application (2021-2032)
- 8.3 North America Epilepsy Devices Market Size by Country
- 8.3.1 North America Epilepsy Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Epilepsy Devices Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Epilepsy Devices Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Epilepsy Devices Market Size by Type
- 9.1.1 Europe Epilepsy Devices Revenue by Type (2021-2032)
- 9.1.2 Europe Epilepsy Devices Sales by Type (2021-2032)
- 9.1.3 Europe Epilepsy Devices Price by Type (2021-2032)
- 9.2 Europe Epilepsy Devices Market Size by Application
- 9.2.1 Europe Epilepsy Devices Revenue by Application (2021-2032)
- 9.2.2 Europe Epilepsy Devices Sales by Application (2021-2032)
- 9.2.3 Europe Epilepsy Devices Price by Application (2021-2032)
- 9.3 Europe Epilepsy Devices Market Size by Country
- 9.3.1 Europe Epilepsy Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Epilepsy Devices Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Epilepsy Devices Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Epilepsy Devices Market Size by Type
- 10.1.1 China Epilepsy Devices Revenue by Type (2021-2032)
- 10.1.2 China Epilepsy Devices Sales by Type (2021-2032)
- 10.1.3 China Epilepsy Devices Price by Type (2021-2032)
- 10.2 China Epilepsy Devices Market Size by Application
- 10.2.1 China Epilepsy Devices Revenue by Application (2021-2032)
- 10.2.2 China Epilepsy Devices Sales by Application (2021-2032)
- 10.2.3 China Epilepsy Devices Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Epilepsy Devices Market Size by Type
- 11.1.1 Asia Epilepsy Devices Revenue by Type (2021-2032)
- 11.1.2 Asia Epilepsy Devices Sales by Type (2021-2032)
- 11.1.3 Asia Epilepsy Devices Price by Type (2021-2032)
- 11.2 Asia Epilepsy Devices Market Size by Application
- 11.2.1 Asia Epilepsy Devices Revenue by Application (2021-2032)
- 11.2.2 Asia Epilepsy Devices Sales by Application (2021-2032)
- 11.2.3 Asia Epilepsy Devices Price by Application (2021-2032)
- 11.3 Asia Epilepsy Devices Market Size by Country
- 11.3.1 Asia Epilepsy Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Epilepsy Devices Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Epilepsy Devices Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Epilepsy Devices Market Size by Type
- 12.1.1 SAMEA Epilepsy Devices Revenue by Type (2021-2032)
- 12.1.2 SAMEA Epilepsy Devices Sales by Type (2021-2032)
- 12.1.3 SAMEA Epilepsy Devices Price by Type (2021-2032)
- 12.2 SAMEA Epilepsy Devices Market Size by Application
- 12.2.1 SAMEA Epilepsy Devices Revenue by Application (2021-2032)
- 12.2.2 SAMEA Epilepsy Devices Sales by Application (2021-2032)
- 12.2.3 SAMEA Epilepsy Devices Price by Application (2021-2032)
- 12.3 SAMEA Epilepsy Devices Market Size by Country
- 12.3.1 SAMEA Epilepsy Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Epilepsy Devices Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Epilepsy Devices Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Epilepsy Devices Value Chain Analysis
- 13.1.1 Epilepsy Devices Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Epilepsy Devices Production Mode & Process
- 13.2 Epilepsy Devices Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Epilepsy Devices Distributors
- 13.2.3 Epilepsy Devices Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst